191 related articles for article (PubMed ID: 20238302)
1. Impact of hepatitis virus and aging on DNA methylation in human hepatocarcinogenesis.
Nishida N
Histol Histopathol; 2010 May; 25(5):647-54. PubMed ID: 20238302
[TBL] [Abstract][Full Text] [Related]
2. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
Yang B; Guo M; Herman JG; Clark DP
Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.
Nishida N; Nagasaka T; Nishimura T; Ikai I; Boland CR; Goel A
Hepatology; 2008 Mar; 47(3):908-18. PubMed ID: 18161048
[TBL] [Abstract][Full Text] [Related]
4. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma.
Feitelson MA
Cancer Lett; 2006 Jul; 239(1):10-20. PubMed ID: 16154256
[TBL] [Abstract][Full Text] [Related]
5. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.
Um TH; Kim H; Oh BK; Kim MS; Kim KS; Jung G; Park YN
J Hepatol; 2011 May; 54(5):939-47. PubMed ID: 21145824
[TBL] [Abstract][Full Text] [Related]
6. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
7. Association of 32-bp deletion polymorphism and promoter methylation of
Badawy AA; El-Rabat A; Elshazly TA; Ali SA; Alruwaili AM; Gad DF; Dawoud MG; Elmasry EE; Zaki ME
Br J Biomed Sci; 2019 Oct; 76(4):195-197. PubMed ID: 31109254
[No Abstract] [Full Text] [Related]
8. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of promoter region of SPINT2/HAI-2 gene: an epigenetic mechanism in hepatitis C virus-induced hepatocarcinogenesis.
Ramadan RA; Zaki MA; Awad AM; El-Ghalid LA
Genet Test Mol Biomarkers; 2015 Jul; 19(7):399-404. PubMed ID: 26030814
[TBL] [Abstract][Full Text] [Related]
10. Methylation degree of metalloproteinase inhibitor RECK gene: Links to RECK protein level and hepatocellular carcinoma in chronic HCV infection patients.
Abo El-Khair SM; Elalfy H; Diasty M; Ebrahim EE; Elsamanoudy AZ
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22886. PubMed ID: 34392581
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
12. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection.
Zhang F; Fan YC; Mu NN; Zhao J; Sun FK; Zhao ZH; Gao S; Wang K
J Viral Hepat; 2014 Apr; 21(4):241-50. PubMed ID: 24597692
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanism of hepatocarcinogenesis].
Imazeki F; Saisho H
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2154-61. PubMed ID: 10635298
[TBL] [Abstract][Full Text] [Related]
16. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
Araújo OC; Rosa AS; Fernandes A; Niel C; Villela-Nogueira CA; Pannain V; Araujo NM
PLoS One; 2016; 11(4):e0153796. PubMed ID: 27078152
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and epigenetic instability in human hepatocarcinogenesis.
Nishida N; Kudo M
Dig Dis; 2013; 31(5-6):447-53. PubMed ID: 24281019
[TBL] [Abstract][Full Text] [Related]
18. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus-induced hepatocarcinogenesis.
Bartosch B; Thimme R; Blum HE; Zoulim F
J Hepatol; 2009 Oct; 51(4):810-20. PubMed ID: 19545926
[TBL] [Abstract][Full Text] [Related]
20. Methylation of serum insulin-like growth factor-binding protein 7 promoter in hepatitis B virus-associated hepatocellular carcinoma.
Li F; Fan YC; Gao S; Sun FK; Yang Y; Wang K
Genes Chromosomes Cancer; 2014 Jan; 53(1):90-7. PubMed ID: 24142767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
